Ministry of Health and Welfare Holds Public-Private Council for Pharmaceutical Industry Innovation
Discussions Held on Improving CSO Commission Structure and Oversight

As the number of pharmaceutical sales promotion agents (CSOs) rapidly increases, the government is strengthening its oversight and management of these entities. The aim is to enhance transparency and accountability in pharmaceutical promotion by improving sales structures criticized for the proliferation of small-scale businesses, high and performance-based commission rates, and multi-layered subcontracting practices.


Strengthening Management of Pharmaceutical Sales Promotion Agents... Addressing Proliferation of Small-Scale Businesses and Multi-Level Subcontracting Structure View original image

On September 17, the Ministry of Health and Welfare announced that it held the "2nd Pharmaceutical Industry Innovation Public-Private Council" at the Korea Press Center in Jung-gu, Seoul, where it discussed measures to strengthen the management and supervision of pharmaceutical sales promotion agents (CSOs).


CSOs are businesses that are entrusted by pharmaceutical companies and similar entities to carry out pharmaceutical sales and promotion work. As pharmaceutical companies pursue greater specialization in their sales and promotion, and demand for external outsourcing has increased, the relevant market has expanded rapidly.


As of 2024, there are about 15,000 CSOs operating domestically, but approximately 70% consist of one-person businesses, indicating a glut of small-scale enterprises. Furthermore, practices such as paying high commissions, setting commissions in accordance with sales performance, and implementing multi-level subcontracting of sales work to other firms have become prevalent.


There are growing concerns that such structures could undermine the transparency and accountability of the pharmaceutical sales and promotion process, leading to increasing calls to improve the effectiveness of managerial oversight.


During the council meeting, participants reviewed the current CSO management system, shared problems encountered in sales processes, and discussed practical ways to strengthen oversight and identify effective improvements. The government intends to use the opinions gathered from the council and expert recommendations to redefine the role of CSOs and develop strategies for the advancement of the pharmaceutical industry.



Jung Kyungsil, policy chief of the Ministry of Health and Welfare, stated, "As the CSO market rapidly expands and the types of sales activities diversify, it is crucial to establish the institutional foundation to ensure transparency and accountability in pharmaceutical sales," adding, "Based on a wide range of on-site opinions and expert advice, we will prepare measures to strengthen CSO management and oversight."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing